Drug class
Diagnostic radiopharmaceutical; tau positron-emission tomography (PET) imaging agent
Mechanism of action
A fluorine-18-labelled tracer that binds to aggregated tau neurofibrillary tangles in the brain. The spatial distribution and density of retained tracer are assessed by PET imaging.
General use cases
- PET imaging to estimate the density and distribution of aggregated tau neurofibrillary tangles in adults with cognitive impairment who are being evaluated for Alzheimer’s disease; it is an adjunct to other diagnostic evaluations.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
